Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?

by Bibby, M. C.
Published 1991

C-type and intracisternal A-type virus particles during epidermal carcinogenesis by tobacco smoke condensate in BALB/c mice.

by Bibby, M. C., Smith, G. M.
Published 1977

Increase in type A virus particles induced in BALB/c mouse epidermis during chemical carcinogenesis.

by Bibby, M. C., Smith, G. M.
Published 1975

Characterisation and chemosensitivity of a well-differentiated murine transplantable adenocarcinoma of the colon.

by Double, J. A., Bibby, M. C.
Published 1983

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).

by Bibby, M. C., Double, J. A., Loadman, P. M.
Published 1988

The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.

by Bibby, M. C., Phillips, R. M., Double, J. A.
Published 1991

Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.

by Bibby, M. C., Double, J. A., Mughal, M. A.
Published 1981

Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.

by Burger, A. M., Bibby, M. C., Double, J. A.
Published 1997

Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).

by Hussey, H. J., Bibby, M. C., Tisdale, M. J.
Published 1996

Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.

by Double, J. A., Bibby, M. C., Loadman, P. M.
Published 1986

The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.

by Bibby, M. C., Double, J. A., Wahed, I. A., Hirbawi, N., Baker, T. G.
Published 1988

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.

by Bibby, M. C., Loadman, P. M., al-Ghabban, A. F., Double, J. A.
Published 1992

In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.

by Phillips, R. M., Hulbert, P. B., Bibby, M. C., Sleigh, N. R., Double, J. A.
Published 1992

The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.

by Quinn, P. K., Bibby, M. C., Cox, J. A., Crawford, S. M.
Published 1992

Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.

by Bibby, M. C., Phillips, R. M., Double, J. A., Pratesi, G.
Published 1991

Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.

by Matthew, A. M., Phillips, R. M., Loadman, P. M., Bibby, M. C.
Published 1993

Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.

by Burger, A. M., Double, J. A., Konopa, J., Bibby, M. C.
Published 1996

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).

by Bibby, M. C., Double, J. A., Phillips, R. M., Loadman, P. M.
Published 1987

EO9: relationship between DT-diaphorase levels and response in vitro and in vivo.

by Collard, J., Matthew, A. M., Double, J. A., Bibby, M. C.
Published 1995

Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.

by Laws, A. L., Matthew, A. M., Double, J. A., Bibby, M. C.
Published 1995